Status:
COMPLETED
Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
Lead Sponsor:
Novosibirsk State University
Collaborating Sponsors:
FSBI "Federal Neurosurgical Center" Novosibirsk, Russia
Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan
Conditions:
Glioma
Glioblastoma Multiforme
Eligibility:
All Genders
18+ years
Brief Summary
This is an exploratory, non-interventional and translational clinical study. The aim of this study is to analyze blood and cerebrospinal fluid metabolomic profile in glioma patients.
Detailed Description
The analysis of metabolic profile in the plasma and CSF could become the new less invasive approach in the establishing diagnosis as well as an important prognostic factor in patients with glioma. The...
Eligibility Criteria
Inclusion
- All patients with suspected newly diagnosed glioma (grade I, II, III or glioblastoma) with planned surgical intervention (resection or biopsy).
- Patient aged 18 years or older
- Patients have to be able to give informed consent
Exclusion
- Prior Radiotherapy to the central nervous system
- Prior Chemotherapy within the last 5 years
- Any prior central nervous system malignancy
- Any surgery during last 6 month
Key Trial Info
Start Date :
March 13 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 11 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03865355
Start Date
March 13 2019
End Date
November 11 2024
Last Update
November 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novosibirsk State University
Novosibirsk, Novosibirsk Oblast, Russia, 630090